Abstract
Aim
To determine the frequency of occurrence, risk factors, clinical spectrum and drugs associated with adverse drug reactions (ADRs) occurring in the coronary care unit (CCU) of a tertiary care hospital.
Methods
This was a retrospective cohort study based on evaluation of the medical records of consecutive patients admitted to the CCU between January 2008 and December 2008. Each prescription was monitored for ADRs, and each ADR was assessed for causality, severity, predictability and preventability by two physicians using relevant scales. The chi-square test and independent t test were used to compare the ADR and non-ADR groups. Multiple binary logistic regression was used to identify risk factors for developing ADRs in the CCU.
Results
Of 595 patients, 152 (25.5%) developed ADRs, of which 45% were potentially preventable. Severe ADRs constituted 28.6% of the total ADRs. Patients who developed an ADR had a longer duration of stay in the hospital (2.8 extra days) (p < 0.05). Hypokalemia/hyperkalemia (22%), bleeding (11%) and cardiac arrhythmias (11%) were the commonest ADRs. The highest rates of ADRs were seen with streptokinase (59.4%). The predictors for developing an ADR in the CCU included renal dysfunction [odds ratio (OR) 1.66, 95% confidence interval (CI) 1.007–2.72], arrhythmias (OR 1.74, 95% CI 1.052–2.87) and polypharmacy with more than ten drugs (OR 11.3, 95% CI 1.45–87.44).
Conclusion
A high frequency of ADR occurrence was identified, with many of the ADRs being potentially preventable. Patients with renal dysfunction or cardiac arrhythmias and those receiving polypharmacy were at an increased risk for developing an ADR in the CCU.
Similar content being viewed by others
Abbreviations
- ADE:
-
Adverse drug event
- ADR:
-
Adverse drug reactions
- CCU:
-
Coronary care unit
- IERB:
-
Institutional Ethical Review Board
References
Krahenbuhl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krahenbuhl S (2007) Drug-related problems in hospitals: a review of the recent literature. Drug Saf 30(5):379–407
Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15):1200–1205
Wester K, Jonsson AK, Spigset O, Druid H, Hagg S (2008) Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 65(4):573–579
Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA et al (1997) The costs of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA 277(4):307–311
Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277(4):301–306
Wroblewski HA, Tisdale JE, Overhaolser BR, Joanna R. Adverse drug events resulting in admissions to a cardiac care unit. J Am Coll Cardiol 2010;(55).
Davies EC, Green CF, Mottram DR, Pirmohamed M (2007) Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2(1):79–87
Mohebbi N, Shalviri G, Salarifar M, Salamzadeh J, Gholami K (2010) Adverse drug reactions induced by cardiovascular drugs in cardiovascular care unit patients. Pharmacoepidemiol Drug Saf 19(9):889–894
World Health Organization (1972) International drug monitoring—the role of national centers. Technical Report No. 498. World Health Organization, Geneva
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239–245
Schumock GT, Thornton JP (1992) Focusing on the preventability of adverse drug reactions. Hosp Pharm 27(6):538
Hartwig SC, Siegel J, Schneider PJ (1992) Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 49(9):2229–2232
Fahimi F, Baniasadi S (2008) Adverse drug reactions in the post coronary care unit inpatients of a teaching hospital. Iranian J Pharm Res 7:223–228
Joshua L, Devi P, Guido S (2009) Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiol Drug Saf 18(7):639–645
Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D et al (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE prevention study group. JAMA 274(1):29–34
Winterstein AG, Sauer BC, Hepler CD, Poole C (2002) Preventable drug-related hospital admissions. Ann Pharmacother 36(7–8):1238–1248
Routledge PA, O'Mahony MS, Woodhouse KW (2003) Adverse drug reactions in elderly patients. Br J Clin Pharmacol 57:121–126
Venulet J, ten Harn M (1996) Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther 34(3):112–129
Rahim SA, Mody A, Pickering J, Devereaux PJ, Yusuf S (2010) Iatrogenic adverse events in the coronary care unit. Circ Cardiovasc Qual Outcomes 2:437–442
Acknowledgments
The authors sincerely and gratefully acknowledge the time, cooperation and effort of the personnel at the medical records department of St. John’s Hospital, Bangalore and the indispensable contribution of Mrs. Sumitra, statistician at St. John’s Research Institute, Bangalore. We also thank Ms. Sandra Sarah, final year medical student, for her contribution to aspects of data entry and the construction of tables and graphs.
Potential conflict of interest
NIL
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Devi, P., Kamath, D.Y., Anthony, N. et al. Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital. Eur J Clin Pharmacol 68, 427–433 (2012). https://doi.org/10.1007/s00228-011-1138-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-011-1138-9